Seastar Medical Holding Corp. (ICU)
3.50
-0.04
(-1.13%)
USD |
NASDAQ |
Sep 21, 16:00
3.50
0.00 (0.00%)
After-Hours: 20:00
Seastar Medical Enterprise Value : 8.255M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 8.255M |
| September 17, 2026 | 8.072M |
| September 16, 2026 | 6.295M |
| September 15, 2026 | 6.040M |
| September 14, 2026 | 6.255M |
| September 11, 2026 | 6.082M |
| September 10, 2026 | 6.508M |
| September 09, 2026 | 6.380M |
| September 08, 2026 | 5.741M |
| September 04, 2026 | 5.869M |
| September 03, 2026 | 5.571M |
| September 02, 2026 | 5.443M |
| September 01, 2026 | 5.912M |
| August 31, 2026 | 6.508M |
| August 28, 2026 | 6.338M |
| August 27, 2026 | 6.380M |
| August 26, 2026 | 6.466M |
| August 25, 2026 | 6.721M |
| August 24, 2026 | 6.764M |
| August 21, 2026 | 7.445M |
| August 20, 2026 | 7.403M |
| August 19, 2026 | 7.104M |
| August 18, 2026 | 7.403M |
| August 17, 2026 | 7.019M |
| August 14, 2026 | 6.721M |
| Date | Value |
|---|---|
| August 13, 2026 | 6.679M |
| August 12, 2026 | 7.488M |
| August 11, 2026 | 8.894M |
| August 10, 2026 | 8.894M |
| August 07, 2026 | 7.147M |
| August 06, 2026 | 6.167M |
| August 05, 2026 | 6.040M |
| August 04, 2026 | 6.764M |
| August 03, 2026 | 6.785M |
| July 31, 2026 | 6.508M |
| July 30, 2026 | 6.721M |
| July 29, 2026 | 7.019M |
| July 28, 2026 | 7.829M |
| July 27, 2026 | 8.382M |
| July 24, 2026 | 9.149M |
| July 23, 2026 | 9.107M |
| July 22, 2026 | 9.746M |
| July 21, 2026 | 9.618M |
| July 20, 2026 | 9.575M |
| July 17, 2026 | 10.21M |
| July 16, 2026 | 11.15M |
| July 15, 2026 | 12.86M |
| July 14, 2026 | 13.62M |
| July 13, 2026 | 13.58M |
| July 10, 2026 | 14.26M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 205.21B |
| AngioDynamics, Inc. | 600.95M |
| Alphatec Holdings, Inc. | 2.063B |
| AtriCure, Inc. | 2.862B |
| Baxter International, Inc. | 18.47B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.73M |
| Revenue (Quarterly) | 0.615M |
| Total Expenses (Quarterly) | 4.345M |
| EPS Diluted (Quarterly) | -0.9133 |
| Gross Profit Margin (Quarterly) | 91.22% |
| Profit Margin (Quarterly) | -606.5% |
| Earnings Yield | -112.3% |
| Normalized Earnings Yield | -112.26 |